Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum-A Toxin for Neurogenic Overactive Bladder in Children with Myelomeningocele
NCT00175123Phase 4Unknown
- Sponsor
- Aarhus University
- Start
- May 2005
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of botulinum toxin type A in neurogenic bladder, sponsored by Aarhus University. Primary endpoint: Bladder capacity and pressures from cystometry at 24 weeks. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on NCT00175123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175123.